COVID-19 Update 5/15/2020

COVID-19 Update | May 15, 2020
Framework for Healthcare Systems Providing Non-COVID-19 Clinical Care During the COVID-19 Pandemic (CDC, May 12)
The Framework for Healthcare Systems Providing Non-COVID-19 Clinical Care During the COVID-19 Pandemic outlines relevant factors for healthcare providers to consider as they expand providing care for patients with conditions other than COVID-19. This framework is just one tool to support decision making about providing non-COVID-19 clinical care. Additional resources are highlighted in this document to help healthcare providers and systems provide the safest care possible while minimizing risk to patients and healthcare personnel.
SHEA Coronavirus News
COVID-19 by the Week Survey
We are tracking SHEA members' experiences week-by-week. Responses are anonymous for a 4-question survey. The first 2 questions are demographic, and the second two are about current status and primary concerns. We are comparing week-to-week, so please respond to each survey. We will summarize the findings after the pandemic decelerates. 
This week (May 10-16):
Status of IDWeek 2020
The premier infectious diseases meeting is still planned for Oct. 21-25 in Philadelphia, Pa. We are monitoring the situation and should meeting in person become impossible, IDWeek will be held virtually and your registration fees will be credited to the virtual event. It is possible a portion will be refunded, but registration rates for a virtual IDWeek have not been established yet.

Updates to the IDWeek status will be posted on the COVID-19 web page and email updates will be sent to registered attendees.
Federal Agency News, Guidance, and Guidelines
Occupational Health
Clinical Care and Treatment
Special Settings and Populations
Testing and Cases

Incident Management
Tools and Resources
SHEA Podcast: We’re All in this Together: COVID-19 Allies in Infection Prevention 

Episodes Available Now:
  • Dialysis in a Crisis with the American Society of Nephrology (ASN)
SHEA Rapid Response Podcast: COVID-19 Update: What We Know Now 
Podcast episodes will launch every Thursday. Each week's episode will include a summary of important news items, medical literature and guidelines, and a discussion around the latest and most important questions surrounding the pandemic. 
Episodes Available Now: 
  • COVID-19 Frequently Asked Questions 
  • Environment of Care & PPE
  • Surge Planning & Testing
  • Diagnostic Testing, Part 1
  • PPE: Conservation & Shortages
  • Diagnostic Testing, Part 2
  • Involving Antimicrobial Stewardship Programs
  • Advocacy around COVID-19
  • PPE: Getting Resourceful with No Resources
  • Taking Care of Yourself
  • Tracing Contacts
  • Answers to Town Hall Questions
  • Staff Policies
SHEA Rapid Response Webinars 
  • Healthcare Facility Outbreak Preparedness
  • SHEA COVID-19 Town Hall 1-6
  • SHEA COVID-19 Town Hall, Round 7 - May 17 | 3:00 pm
    Live Q&A with SHEA Leaders on questions Healthcare Epi is facing during this pandemic.
TFAH’s Portal of COVID-19 Resources (Trust for America’s Health)
CHF Coronavirus Resources (Coalition for Health Funding)
Information for Patients, Visitors and the General Public
Event Announcements
SHEA COVID-19 Town Hall, Round 7
Sunday, May 17 | 3:00 pm ET
Live Q&A with SHEA leaders on questions Healthcare Epi is facing during the COVID-19 pandemic.
Virtual Congressional Briefing - The CDC SPHERES program: Harnessing the Power of Genomics to Bolster our COVID-19 Response (American Microbiology Society)
Wed., May 20 at 1:00 pm ET
The online Congressional briefing will feature updates from Dr. Greg Armstrong and Dr. Duncan McCannell about this unique national genomics consortium that is coordinating SARS-CoV-2 sequencing across the United States, and what it means for disease transmission, and vaccine and therapeutic development.  
RSVP to Mary Lee Watts at A link to the webinar will be sent to registrants prior to the event.
Private Sector Call: Update on the Coronavirus Disease 2019 (COVID-19) Response (CDC)
Monday, May 18, 2020, 4:00 p.m. ET
The presenters will share information about the considerations for public pools, hot tubs, and water playgrounds. We will also have time for questions and answers. Questions can be submitted in advance to with "Partner Call 5/18" in the subject line.
Presenters: Dr. Grant Baldwin (CDC's COVID-19 Community Interventions and At-Risk Task Force) & Dr. Jennifer Murphy (CDC's Water, Sanitation, and Hygiene Team Lead)
Trade Press & Journal Articles
ICHE Coronavirus and COVID-19 Article Collection 
The editors of ICHE have created a page for on the ICHE web site for COVID-19 related articles, commentaries, and letters to the editor. All COVID-19 manuscripts in their accepted form are freely available here. Check back frequently for updates.
Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March–April 2020 (EID, May 14)
Delayed Antibiotic Prescriptions in Ambulatory Care: Reconsidering a Problematic Practice (JAMA, May 13)
News Highlights
Social Media
@ABSteward: COVID-19 Antibiotic Overuse Puts Stewardship Efforts at Risk Researchers worry that copious prescriptions will worsen resistance problem. Featuring @EB_Hirsch @CIDRAP_ASP @ClancyNeil @TmRawson @Dr_Mike_Stevens @SHEA_Epi #IDTwitter #COVID19
@ICHEJournal: New ICHE article, "Respiratory surveillance wards as a strategy to reduce nosocomial transmission of #COVID19 through early detection: the experience of a tertiary hospital in Singapore," available here.
COVID testing and Electroconvulsive therapy “Does anyone have a protocol for serial electroconvulsive therapy (treatments 2-3 times per week) and COVID testing?” ~ Don Dumford, Med Director Infection Prevention, Cleveland Clinic Akron General, Akron, OH
PCR testing prior to surgery in asymptomatic patients “I am curious as to how any of you are addressing...” COVID PCR testing throughout the duration of an inpatient stay and/or during the lead up to an inpatient medical procedure. ~Suji Mathew MS, MD
Federal Policy Updates
Revised Guidance Issued on COVID-19 Diagnostic Tests (FDA, May 14) 
The highlights of each policy within the final guidance follow:
  • Development of laboratory tests that leads to EUA submission – This policy applies to laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) that develop diagnostic tests and pursue an EUA. The FDA notes that this policy remains unchanged from the initial publication on February 29, but some process updates and clarifications have been made. The final guidance details requirements related to validation criteria, reporting of validation results, and the submission of an EUA request within 15 days of the test being distributed.
  • Development of laboratory tests under the authorities of the State – This policy allows states to validate and authorize diagnostic tests developed in clinical labs within the state. The FDA clarifies that this policy remains unchanged from the second publication of this guidance on March 16.
  • Commercial distribution of diagnostic testing to laboratories – This policy applies to commercial manufacturers that seek to develop and distribute diagnostic test kits to clinical labs or to healthcare workers for point-of-care testing. The FDA notes that this policy remains unchanged from the second publication of this guidance on March 16, but some process updates and clarifications have been made. The final guidance clarifies that an EUA request should be made within 15 days of distributing the diagnostic tests and provides recommendations regarding the validation of tests.
  • Serological tests – This policy applies to developers of serology tests that identify antibodies to COVID-19. The FDA revised this policy on May 4 to employ stricter validation criteria and clarify that an EUA request must be made within 10 days of the serology test being distributed. Additionally, the guidance provides recommendations for labeling and reporting serology test results.
Protecting the Health of America’s Older Adults During COVID–19 and Beyond Act
Representatives Frankel (D-FL), Bilirakis (R-FL), and Dingell (D-MI) plan to introduced the Protecting the Health of America’s Older Adults During COVID–19 and Beyond Act, which would establish a cross-agency National COVID-19 Resource Center for Older Adults, as well as authorize an Age-Friendly Public Health program at CDC.
Summary - COVID-19: Safely Getting Back to Work and Back to School (Senate HELP Committee Hearing, May 12)
Witnesses: Dr. Anthony Fauci (NIH), Dr. Robert Redfield (CDC), Admiral Brett Giroir (HHS), Dr. Stephen Hahn (FDA)
Witness Testimony  
Q&A Highlights:
  • Reopening Prematurely – Dr. Fauci warned that cities or states that skip checkpoints (e.g., 14 day decrease in case) and prematurely open without the capability to respond effectively may see “spikes that might turn into outbreaks.” 
  • Reopening Guidance – Sen. Chris Murphy (D-CT) described the administration’s reopening guidance as “criminally vague.” Noting media reports suggest the CDC guidance was “shelved by the administration,” he asked why the plan was released and when it would be released. Dr. Redfield explained that the guidance has gone through interagency review and the Coronavirus Task Force is currently review it and added that the guidance would be released “soon.”
  • National Testing Strategy – Ranking Member Murray pressed Admiral Giroir on the administration’s strategic plan on testing. She asked if the plan would include “specific numeric targets for testing capacity, supply chain capacity, and projection of shortages.” Admiral Giroir said that they established targets with the states of over 12 million tests for May and June. Appearing disappointed by the response, Ranking Member Murray pushed for details on the testing needs for the coming months.
  • Contact Tracing – Dr. Redfield noted that the CDC has deployed 500 employees to conduct contact tracing across the country, and 650 more may be deployed through support from the CDC Foundation.
  • Manufacturing Capacity – Dr. Hahn explained the administration’s new program called “operation warp speed”, involving Dr. Collins (NIH Director), Dr. Fauci, Department of Defense, Department of Health and Human Services, and FDA. The program is examining and working to address supply chain issues to ensure supplies are available once vaccines are ready to be produced.
  • Vaccine Coverage – Sen. Bernie Sanders (I-VT) asked if vaccines should be made available regardless of income. Admiral Giroir said that every American “should gain access it. I don’t control it” and “will certainly advocate that everyone is able to receive the vaccine.”
facebook-2.png twitterlogowhite.png
Click here to unsubscribe.
Powered By Higher Logic

4040 Wilson Blvd, Suite 300, Arlington, VA 22203